Provided by Tiger Fintech (Singapore) Pte. Ltd.

FRONTAGE

1.430
+0.1007.52%
Volume:1.68M
Turnover:2.44M
Market Cap:2.91B
PE:470.84
High:1.500
Open:1.330
Low:1.330
Close:1.330
52wk High:1.870
52wk Low:0.470
Shares:2.04B
HK Float Shares:2.04B
Volume Ratio:4.69
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.003
ROE:1.13%
ROA:1.39%
PB:1.10
PE(LYR):470.86
PS:1.48

Loading ...

Company Profile

Company Name:
FRONTAGE
Exchange:
SEHK
Establishment Date:
2018
Employees:
1540
Office Location:
700 Pennsylvania Drive,Exton,Pennsylvania,United States
Zip Code:
19341
Fax:
610 232 0101
Introduction:
Frontage Holdings Corporation is a holding company. It provides laboratory and related services to pharmaceutical and agrochemical companies, as well as bioequivalence clinical and chemical services. The Company has two main divisions: Global Laboratory Services and Global Drug Discovery & Development Services. The Global Laboratory Services division offers laboratory testing support for clients involved in drug development. The Global Drug Discovery & Development Services division includes Drug Development Unit, the Drug Discovery Unit, and the Pharmaceutical Product Development Unit. Its Global Laboratory Services encompass regulated and non-regulated bioanalysis (both small and large molecules), biomarkers, genomics, manufacturing and controls analytical testing, and central laboratory services. The Drug Development Unit includes drug metabolism and pharmacokinetics, Safety and Toxicology. The Company's segments include North America and Europe and PRC.

Directors

Name
Position
LI Song
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee
Wentao Zhang
Executive Director
Zhongping Lin
Executive Director
LI YIFAN
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit and Risk Management Committee Chairman
LIU Er Fei
Independent Director,Member of the Nomination Committee,Audit and Risk Management Committee Member
WANG Jin Song
Independent Director,Chairman of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
Yin Zhuan
Director,Member of the Nomination Committee
WU Hao
Director,Audit and Risk Management Committee Member

Shareholders

Name
Position
LIN Zhong Ping
CEO
Wentao Zhang
CEO
WANG Huan
Acting CFO
ZHANG Ying Lun
Corporate Secretary